Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Turn out the Light: 'Switch' Determines Cancer Cell Fate

Published: Friday, May 03, 2013
Last Updated: Friday, May 03, 2013
Bookmark and Share
Like picking a career or a movie, cells have to make decisions – and cancer results from cells making wrong decisions.

At the cellular level, wrong decisions can be made right. Cornell engineers with clinicians at Weill Cornell Medical College have discovered that colon cancer stem cells, a particularly malignant population of cancer cells, are able to switch between the decision to proliferate or to remain constant – and this “switch” is controlled by a little-studied molecule called microRNA.

The research, published online May 2 in the journal Cell Stem Cell, was led by senior author Xiling Shen, assistant professor of electrical and computer engineering, with clinician Steven M. Lipkin, associate professor of medicine at Weill Cornell Medical College. The multidisciplinary work involves engineers, biologists and doctors.

Cancer stem cells live in tumors and share characteristics of regular stem cells – they “decide” what to become. In early stage, noninvasive tumors, say the researchers, cancer stem cells are biased toward asymmetric division – meaning the population of cancer stem cells remains constant. But in more malignant, late-stage tumors, these cells tend to promote symmetric division, or fast proliferation, by making identical copies of themselves, which leads to invasion and metastasis, or spread of cancer cells.

MicroRNA, known as a non-coding RNA, is a relatively understudied molecule because unlike regular messenger RNA, it doesn’t make proteins, and therefore, its importance in biological functions has not been well characterized.

“MicroRNA, which is usually thought to be dispensable in normal tissue, has been largely overlooked in its role in determining cancer outcomes,” Shen said.

Using clinically relevant samples from colon cancer patients at NewYork-Presbyterian/Weill Cornell Medical Center who provided permission, the team conducted experiments to determine a link between the presence of a microRNA called miR-34a and tumor size, metastatic potential and chemoresistance in cancer patients.

They discovered that microRNA acts as a sharp on-off switch that controls the mode of division of colon cancer stem cells, symmetric or asymmetric, in a mechanism distinct from protein regulators.
By changing the number of binding sites of microRNA in a given sample, the dynamics of the system can be tuned to be sharp or gradual – lots of microRNA binding sites make the switch very sharp; fewer make the switch more gradual.

By studying how microRNA affects cancer in real patient tumors, the researchers hypothesize that late-stage tumors try to shut down the switching mechanism so that cells are free to produce even more cancer stem cells. This is why therapies that might arise from this discovery would need to be “upstream” of the microRNA binding – that is, it’s better to control the switching at the microRNA level rather than just increasing the population of microRNA later, when the cancer has already spread.

Shen, a trained electrical engineer, confesses a longtime fascination with the concept of how cells make decisions – the classical example being stem cells, which must decide whether and when to differentiate into myriad other types of cells and how to spatially allocate them. But what controls this process? Shen likes to think of cells as circuits – how they are wired determines not only their decision-making prowess, but also how robust those decisions are.

The study, “A MicroRNA miR-34a Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells,” was supported by the National Institutes of Health, National Science Foundation, Defense Advanced Research Projects Agency, Cornell Nanobiotechnology Center, Cornell Stem Cell Program and a gift from philanthropist Matthew Bell.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Wednesday, June 29, 2016
Pathogen Takes Control of Gypsy Moth Populations
A new fungal pathogen is killing gypsy moth caterpillars and crowding out communities of pathogens and parasites that previously destroyed these moth pests.
Tuesday, April 26, 2016
Eating Green Could be in Your Genes
Genetic variation uncovered that has evolved in populations that have historically favored vegetarian diets, such as in India, Africa and parts of East Asia.
Friday, April 01, 2016
$4.8M USAID Grant to Improve Food Security
To strengthen capacity to develop and disseminate genetically engineered eggplant in Bangladesh and the Philippines, the USAID has awarded Cornell a $4.8 million, three-year cooperative grant.
Friday, April 01, 2016
Proteins Seek, Attack, Destroy Tumor Cells in Bloodstream
Using white blood cells to ferry potent cancer-killing proteins through the bloodstream virtually eliminates metastatic prostate cancer in mice, Cornell researchers have confirmed.
Friday, January 15, 2016
Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
Synthetic Immune Organ Produces Antibodies
Cornell engineers have created a functional, synthetic immune organ that produces antibodies and can be controlled in the lab, completely separate from a living organism.
Friday, June 12, 2015
On Planes, Savory Tomato Becomes Favored Flavor
Study shows the effect that airplane noise has on passengers' taste preferences.
Friday, May 15, 2015
$5.5M NSF Grant Aims to Improve Rice Crops with Genome Editing
Researchers to precisely target, cut, remove and replace DNA in a living cell to improve rice.
Friday, May 08, 2015
'Shield' Gives Tricky Proteins a New Identity
Solubilization of Integral Membrane Proteins with high Levels of Expression.
Saturday, April 11, 2015
DNA Safeguard May Be Key In Cancer Treatment
Cornell researchers have developed a new technique to understand the actions of key proteins required for cancer cells to proliferate.
Monday, March 09, 2015
A ‘STAR’ is Born: Engineers Devise Genetic 'On' Switch
A new “on” switch to control gene expression has been developed by Cornell scientists.
Tuesday, February 03, 2015
Bacteria Be Gone!
New technology keeps bacteria from sticking to surfaces.
Monday, January 19, 2015
On the Environmental Trail of Food Pathogens
Learning where Listeria dwells can aid the search for other food pathogens.
Tuesday, December 23, 2014
Chemists Show That ALS is a Protein Aggregation Disease
Using a technique that illuminates subtle changes in individual proteins, chemistry researchers at Cornell have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis (ALS).
Thursday, October 23, 2014
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Core-Shell Columns in HPLC: Food Analysis Applications
Explore the most recent applications of core-shell columns in food analysis.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!